| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/07/2008 | US20080033051 crystallization by combining O-desmethylvenlafaxine starting material and solvent selected from ethanol, tetrahydrofuran, isopropyl alcohol, heating, dissolving, recovering; inhibits re-uptake of norepinephrine and serotonin; alternative to tricyclic anti-depressants and selective re-uptake inhibitors |
| 02/07/2008 | US20080033050 Method of treating thermoregulatory disfunction with paroxetine |
| 02/07/2008 | US20080033049 Hydroxy-Biphenyl-Carbaldehyde Oxime Derivatives and Their Use As Estrogenic Agents |
| 02/07/2008 | US20080033048 Piggyback bifunctional vasodilators |
| 02/07/2008 | US20080033047 Combination/association of adapalene and benzoyl peroxide for treating acne lesions |
| 02/07/2008 | US20080033046 Treatment of myocardial infarction with 11HSD1 inhibitors |
| 02/07/2008 | US20080033045 Treatment of psychiatric disorders |
| 02/07/2008 | US20080033044 Crystal form; controlled release tablet of bupropion hydrobromide for reducing the ratio of the maximum/minimum plasma bupropion hydrobromide concentration (Cmax/Cmin) while maintaining bupropion plasma levels within the therapeutic window upon administration to a patient; more stable than buproin hcl |
| 02/07/2008 | US20080033043 Modified release formulations of a bupropion salt |
| 02/07/2008 | US20080033042 Urea-and urethane-substituted acylureas, process for their preparation and their use |
| 02/07/2008 | US20080033041 Use of phenylethanolaminotetralines for preparing anxiolytic drugs |
| 02/07/2008 | US20080033040 Methods And Compositions For Screening Involving Endothelial Cells Under Shearing Conditions |
| 02/07/2008 | US20080033039 Combination of ceramide and oxaliplatin for inducing cell death and uses thereof in treating cancer |
| 02/07/2008 | US20080033038 Compositions of polyphenols and methods of use |
| 02/07/2008 | US20080033037 Utilisation de la silymarine et/ou de ses constituants comme agents promoteur de la pigmentation de la peau ou des cheveux |
| 02/07/2008 | US20080033036 Composition and Method for Promoting Hair Growth |
| 02/07/2008 | US20080033035 Animal extract from a deep-water sponge of the genus Leiodermatium collected in the US and Bahamas; polyene macrolide antibiotics; multidrug resistant cancers; potentinhibition of mitosis by causing a G2/M block; anticarcinogenic, -tumor, -proliverative and -inflammatory agents; autoimmune diseases |
| 02/07/2008 | US20080033034 Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque |
| 02/07/2008 | US20080033033 8-azaprostaglandin derivatives and medical use thereof |
| 02/07/2008 | US20080033032 Novel Polymorphs Of The Potassium Salt Of Atorvastatin |
| 02/07/2008 | US20080033031 Antibiotic compounds, compositions and methods of treatment |
| 02/07/2008 | US20080033030 Fluvastatin sodium pharmaceutical compositions |
| 02/07/2008 | US20080033029 Treating Digestive Tract Conditions |
| 02/07/2008 | US20080033028 Such as (+/-)-[9-(4-chlorobenzyl)-6-fluoro-8-methanesulfonyl-2, 3,4,9-tetrahydro-1H-carbazol-1-yl]acetic acid; prostaglandin receptor antagonists; antihistamines; nasal decongestion, rhinitis |
| 02/07/2008 | US20080033027 Drug combination pharmaceutical compositions and methods for using them |
| 02/07/2008 | US20080033025 administering e.g. 5-[5-(1-trifluoromethyl-4-Chloro-phenyl)-furan-2-ylmethylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-acetic acid as a bactericide to inhibit lethal factor (LF) protease activity of anthrax toxin |
| 02/07/2008 | US20080033024 Aryl amino acid derivatives as inhibitors for treating inflammation |
| 02/07/2008 | US20080033023 Therapeutic compounds |
| 02/07/2008 | US20080033022 Inhibitors of c-Jun N-terminal kinases (JNK) |
| 02/07/2008 | US20080033019 Cholesterol lowering drug combination |
| 02/07/2008 | US20080033018 Therapeutic Agents For Overactive Bladder |
| 02/07/2008 | US20080033016 Piperidinesulfonylureas and -thioureas, their preparation, their use and pharmaceutical compositions comprising them |
| 02/07/2008 | US20080033015 Histone Deacetylase Inhibitors |
| 02/07/2008 | US20080033014 Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin reuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor |
| 02/07/2008 | US20080033013 Pyrazolylphenyl and pyrrolylphenyl inhibitors of lta4h for treating inflammation |
| 02/07/2008 | US20080033012 Enzyme inhibitors |
| 02/07/2008 | US20080033011 Novel benzo[d][1,3]-dioxol derivatives |
| 02/07/2008 | US20080033010 Combination therapy of erdosteine and beta-2 agonists for treating respiratory pathologies characterized by non reversible or partially reversible airway obstruction |
| 02/07/2008 | US20080033009 Solid Pharmaceutical Formulation |
| 02/07/2008 | US20080033008 Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof |
| 02/07/2008 | US20080033007 Substituted Tetrahydroisoquinoline Compounds for Cancer Therapy |
| 02/07/2008 | US20080033006 1,2,4-Triazolo[ 1,5-A] Pyridines as Gastric Acid Secretion Inhibitors |
| 02/07/2008 | US20080033005 Methods for the treatment of multiple sclerosis |
| 02/07/2008 | US20080033004 Synthesis of grossularines-1 and analogs thereof and method of use |
| 02/07/2008 | US20080033003 Camptothecins Conjugated in Position 7 to Cyclic Peptides as Cytostatic Agents |
| 02/07/2008 | US20080033002 Modulators of muscarinic receptors |
| 02/07/2008 | US20080033001 Derivatives of Variolin B |
| 02/07/2008 | US20080033000 Identification of CDKI pathway inhibitors |
| 02/07/2008 | US20080032999 viricides for treating a hepatitis C virus infection |
| 02/07/2008 | US20080032998 Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 02/07/2008 | US20080032997 (5S)-5-methyl-5-({[6-[2-(trifluoromethyl)pyrimidin-5-yl]-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)imidazolidine-2,4-dione; asthma, rhinitis, chronic obstructive pulmonary diseases (COPD), arthritis (such as rheumatoid arthritis and osteoarthritis), atherosclerosis, cancer |
| 02/07/2008 | US20080032996 Substituted Quinazoline or Pyridopyrimidine Derivative |
| 02/07/2008 | US20080032995 Aldh-2 inhibitors in the treatment of drug addiction |
| 02/07/2008 | US20080032994 adducts of 2,6-di-tert-butyl-4-methylphenol (BHT) with azole compounds, e.g. ketoconazole, itraconazole, pramiconazole; skin fungal disorder associated with Trichophyton, Candida, Pityrosporum or Malassezia, or bacterial disorder associated with Staphylococci, Streptococci or Propionbacterium acnes |
| 02/07/2008 | US20080032993 Substituted heterocyclic compounds |
| 02/07/2008 | US20080032992 New Pyridine Analogues V |
| 02/07/2008 | US20080032991 2, 8-disubstituted Naphthyridine Derivatives |
| 02/07/2008 | US20080032990 Inhibitors of advanced glycation end products |
| 02/07/2008 | US20080032989 Method of treating inflammatory diseases using tyroskine kinase inhibitors |
| 02/07/2008 | US20080032988 Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use |
| 02/07/2008 | US20080032987 Quercetin-containing compositions |
| 02/07/2008 | US20080032986 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| 02/07/2008 | US20080032985 4-Substituted Quinoline Derivatives, Method and Intermediates for Their Preparation and Pharmaceutical Compositions Containing Them |
| 02/07/2008 | US20080032984 1-Ethyl-6-methyl-3-phenyl-1H-pyrinido[5,4-e]1,2,4]triazine-5,7-dione, used for lowering blood sugar, treating non-insulin dependent diabetes and insulin resistance; antidiabetic agents |
| 02/07/2008 | US20080032983 Ortho-Substituted N'-Benzylidene-(3-Hydroxyphenyl)Acethydrazides |
| 02/07/2008 | US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
| 02/07/2008 | US20080032981 Aryl n-cyanoguanidines and methods related thereto |
| 02/07/2008 | US20080032980 1-Carbonyl-3,5-diphenyl-4,5-dihydro-1H-pyrazoles such as 1-acetyl-4-(1-{[3-(2,5-difluorophenyl)-5-methyl-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl]carbonyl}propyl)piperazine trifluoroacetate that are useful for treating cancer |
| 02/07/2008 | US20080032979 Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors |
| 02/07/2008 | US20080032978 Soluble epoxide hydrolase inhibitors |
| 02/07/2008 | US20080032977 Alkyne-substituted pyridone compounds and methods of use |
| 02/07/2008 | US20080032976 Histamine 3 receptor antagonists and/or inverse agonists; for obesity, metabolic syndrome (syndrome X), and other eating disorders; (4-cyclopentyl-piperazin-1-yl)-[3-(1-isopropyl-piperidin -4-yl)-l H-indol-6-yl]-methanone |
| 02/07/2008 | US20080032975 Substituted Fused Pyrroleoximes and Fused Pyrazoleoximes |
| 02/07/2008 | US20080032974 Compounds and therapeutical use thereof |
| 02/07/2008 | US20080032973 2-Quinazolinone compounds and methods of use |
| 02/07/2008 | US20080032972 Pyridopyrazines and derivatives thereof as alk and c-Met inhibitors |
| 02/07/2008 | US20080032971 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders |
| 02/07/2008 | US20080032970 Amide Derivatives of 7-Amino-3-Phenyl-Dihydropyrimido[4,5-D]Pyrimidinones, Their Manufacture and Use as Pharmaceutical Agents |
| 02/07/2008 | US20080032969 Novel compounds |
| 02/07/2008 | US20080032968 New compounds |
| 02/07/2008 | US20080032967 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase |
| 02/07/2008 | US20080032966 Small Molecule Inhibitors of Mrp1 and Other Multidrug Transporters |
| 02/07/2008 | US20080032965 Method for enhancing cognitive function |
| 02/07/2008 | US20080032964 Process for the synthesis of azetidinone |
| 02/07/2008 | US20080032963 Aminopyrimidines useful as kinase inhibitors |
| 02/07/2008 | US20080032962 Stabilized Freeze-Dried Formulation for Cephalosporin Derivatives |
| 02/07/2008 | US20080032961 Therapy employing LXRalpha modolators |
| 02/07/2008 | US20080032960 PI3 kinase antagonists |
| 02/07/2008 | US20080032959 Estrogen Receptor Modulators |
| 02/07/2008 | US20080032958 Withanolide compounds as inhibitors of fibrosis and identification of molecular targets for anti-fibrotic drug development |
| 02/07/2008 | US20080032957 liver, lung, skin, breast, brain glioma, colon and rectum, stomach, head and neck, leukemia, malignant lymphoma, sarcoma, malignant melanoma, myeloma, and metastasis cancers |
| 02/07/2008 | US20080032956 2-Ethyl and 2-Ethylidene-19-Nor-Vitamin D Compounds |
| 02/07/2008 | US20080032955 Vitamin d3 analogues for the prevention and treatment of bone disorders |
| 02/07/2008 | US20080032954 Vascular Damaging Agents for Administration as an Intravenous Infusion |
| 02/07/2008 | US20080032953 Method For Inhibiting Prebiotic Effect Of Food Proteins |
| 02/07/2008 | US20080032952 Combination Therapies Employing Nicotinic Acid Derivatives or Fibric Acid Derivatives |
| 02/07/2008 | US20080032951 Ophthalmic Compositions For Treating Ocular Hypertension |
| 02/07/2008 | US20080032950 Neurologically-Active Compounds |
| 02/07/2008 | US20080032948 administering folic acid, methylmalonic acid lowering agent (vitamin B12, hydroxycobalamin, cyano-10-chlorocobalamin, aquocobalamin perchlorate, aquo-10-cobalamin perchlorate, azidocobalamin, cobalamin, cyanocobalamin, or chlorocobalamin), then pemetrexed disodium |
| 02/07/2008 | US20080032947 Pka ligands and polynucleotides encoding pka ligands |